500 related articles for article (PubMed ID: 25883084)
21. CHANGES IN SUBFOVEAL CHOROIDAL THICKNESS AFTER INTRAVITREAL DEXAMETHASONE IMPLANT THERAPY FOR DIABETIC MACULAR EDEMA.
Moon KY; Choi SY; Song JH
Retina; 2021 Jun; 41(6):1283-1292. PubMed ID: 33323903
[TBL] [Abstract][Full Text] [Related]
22. Intravitreal dexamethasone implant for macular edema secondary to retinal vein occlusion: 12-month follow-up and prognostic factors.
Maggio E; Polito A; Guerriero M; Pertile G
Ophthalmologica; 2014; 232(4):207-15. PubMed ID: 25471901
[TBL] [Abstract][Full Text] [Related]
23. Monthly microperimetry (MP1) measurement of macular sensitivity after dexamethasone implantation (Ozurdex) in retinal vein occlusions.
Winterhalter S; Vom Brocke GA; Klamann MK; Müller B; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):1873-82. PubMed ID: 25576170
[TBL] [Abstract][Full Text] [Related]
24. Comparison of subfoveal choroidal thickness in eyes with CRVO and BRVO.
Tang F; Xu F; Zhong H; Zhao X; Lv M; Yang K; Shen C; Huang H; Lv J; Zeng S; Li M; Chen Q
BMC Ophthalmol; 2019 Jun; 19(1):133. PubMed ID: 31226968
[TBL] [Abstract][Full Text] [Related]
25. Comparison of choroidal thickness changes following intravitreal dexamethasone, ranibizumab, and triamcinolone in eyes with retinal vein occlusion.
Yumusak E; Ornek K; Dikel NH
Eur J Ophthalmol; 2016 Nov; 26(6):627-632. PubMed ID: 26847213
[TBL] [Abstract][Full Text] [Related]
26. Effect of intravitreal dexamethasone implant on retinal and choroidal thickness in refractory diabetic macular oedema after multiple anti-VEGF injections.
Kim M; Cho YJ; Lee CH; Lee SC
Eye (Lond); 2016 May; 30(5):718-25. PubMed ID: 26939558
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of foveal photoreceptor layer in eyes with macular edema associated with branch retinal vein occlusion after ozurdex treatment.
Altunel O; Duru N; Goktas A; Ozkose A; Goktas E; Atas M
Int Ophthalmol; 2017 Apr; 37(2):333-339. PubMed ID: 27221365
[TBL] [Abstract][Full Text] [Related]
28. Outcome of intravitreal dexamethasone implant for the treatment of ranibizumab-resistant macular edema secondary to retinal vein occlusion.
Manousaridis K; Peter S; Mennel S
Int Ophthalmol; 2017 Feb; 37(1):47-53. PubMed ID: 27043320
[TBL] [Abstract][Full Text] [Related]
29. Subfoveal choroidal thickness change after intravitreal ranibizumab for idiopathic choroidal neovascularization.
Cao XS; Peng XY; You QS; Zhang YP; Jonas JB
Retina; 2014 Aug; 34(8):1554-9. PubMed ID: 24667570
[TBL] [Abstract][Full Text] [Related]
30. RELATIONSHIP BETWEEN RETINAL THICKNESS AND VISUAL ACUITY IN EYES WITH RETINAL VEIN OCCLUSION TREATED WITH DEXAMETHASONE IMPLANT.
Danis RP; Sadda S; Jiao J; Li XY; Whitcup SM
Retina; 2016 Jun; 36(6):1170-6. PubMed ID: 26655606
[TBL] [Abstract][Full Text] [Related]
31. Exploring the morphological and functional retinal changes after dexamethasone intravitreal implant (Ozurdex®) in macular edema due to retinal vein occlusion.
Parravano M; Oddone F; Boccassini B; Giorno P; Chiaravalloti A; Tedeschi M; Scarinci F; Varano M
Ophthalmic Res; 2014; 51(3):153-60. PubMed ID: 24642474
[TBL] [Abstract][Full Text] [Related]
32. The efficacy of intravitreal dexamethasone implant as the first-line treatment for retinal vein occlusion-related macular edema in a real-life scenario.
Simsek M; Citirik M; Ozates S; Ozkoyuncu D
Indian J Ophthalmol; 2018 Jun; 66(6):831-836. PubMed ID: 29785994
[TBL] [Abstract][Full Text] [Related]
33. Optical coherence tomography angiography in retinal vein occlusion treated with dexamethasone implant: a new test for follow-up evaluation.
Glacet-Bernard A; Sellam A; Coscas F; Coscas G; Souied EH
Eur J Ophthalmol; 2016 Aug; 26(5):460-8. PubMed ID: 27405288
[TBL] [Abstract][Full Text] [Related]
34. Effect of intravitreal dexamethasone implant on intra-ocular cytokines and chemokines in eyes with retinal vein occlusion.
Rezar-Dreindl S; Eibenberger K; Pollreisz A; Bühl W; Georgopoulos M; Krall C; Dunavölgyi R; Weigert G; Kroh ME; Schmidt-Erfurth U; Sacu S
Acta Ophthalmol; 2017 Mar; 95(2):e119-e127. PubMed ID: 27417275
[TBL] [Abstract][Full Text] [Related]
35. The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series.
Lin CJ; Chen HS; Su CW; Tien PT; Lin JM; Chen WL; Kuo CY; Lai CT; Tsai YY
J Ocul Pharmacol Ther; 2017 Dec; 33(10):763-772. PubMed ID: 28949790
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of Combination Therapy using Aflibercept and Dexamethasone Intravitreal Implant versus Dexamethasone Monotherapy for Macular Edema Secondary to Retinal Vein Occlusion.
Harb W; Chidiac G; Harb G
Middle East Afr J Ophthalmol; 2021; 28(1):18-22. PubMed ID: 34321818
[TBL] [Abstract][Full Text] [Related]
37. Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension.
Theodoropoulou S; Ellabban AA; Johnston RL; Cilliers H; Mohamed Q; Sallam AB
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):725-732. PubMed ID: 27878430
[TBL] [Abstract][Full Text] [Related]
38. Regional Choroidal Thickness Changes in Branch Retinal Vein Occlusion with Macular Edema.
Kim KH; Lee DH; Lee JJ; Park SW; Byon IS; Lee JE
Ophthalmologica; 2015; 234(2):109-18. PubMed ID: 26305536
[TBL] [Abstract][Full Text] [Related]
39. Choroidal Changes After Suprachoroidal Injection of Triamcinolone Acetonide in Eyes With Macular Edema Secondary to Retinal Vein Occlusion.
Willoughby AS; Vuong VS; Cunefare D; Farsiu S; Noronha G; Danis RP; Yiu G
Am J Ophthalmol; 2018 Feb; 186():144-151. PubMed ID: 29199012
[TBL] [Abstract][Full Text] [Related]
40. Anatomical and functional recurrence after dexamethasone intravitreal implants: a 6-month prospective study.
Fortoul V; Denis P; Kodjikian L
Eye (Lond); 2015 Jun; 29(6):769-75. PubMed ID: 25853447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
